Complete Sequence of HLA-B27 CDNA Identified Through the Characterization of Structural Markers Unique to the HLA-A, -B, and -C Allelic Series
Overview
Authors
Affiliations
Antigen HLA-B27 is a high-risk genetic factor with respect to a group of rheumatoid disorders, especially ankylosing spondylitis. A cDNA library was constructed from an autozygous B-cell line expressing HLA-B27, HLA-Cw1, and the previously cloned HLA-A2 antigen. Clones detected with an HLA probe were isolated and sorted into homology groups by differential hybridization and restriction maps. Nucleotide sequencing allowed the unambiguous assignment of cDNAs to HLA-A, -B, and -C loci. The HLA-B27 mRNA has the structural features and the codon variability typical of an HLA class I transcript but it specifies two uncommon amino acid replacements: a cysteine in position 67 and a serine in position 131. The latter substitution may have functional consequences, because it occurs in a conserved region and at a position invariably occupied by a species-specific arginine in humans and lysine in mice. The availability of the complete sequence of HLA-B27 and of the partial sequence of HLA-Cw1 allows the recognition of locus-specific sequence markers, particularly, but not exclusively, in the transmembrane and cytoplasmic domains.
Bender K Experientia. 1986; 42(10):1138-47.
PMID: 3533606 DOI: 10.1007/BF01941288.
HLA-B27 and the causes of arthritis: does molecular biology help?.
Archer J, Winrow V Ann Rheum Dis. 1987; 46(9):713-5.
PMID: 3499875 PMC: 1002239. DOI: 10.1136/ard.46.9.713.
Comparison of the primary structure of class I molecules.
Maloy W Immunol Res. 1987; 6(1-2):11-29.
PMID: 3305734 DOI: 10.1007/BF02918101.
Isolation, expression, and the primary structure of HLA-Cw1 and HLA-Cw2 genes: evolutionary aspects.
Gussow D, Rein R, Meijer I, de Hoog W, Seemann G, Hochstenbach F Immunogenetics. 1987; 25(5):313-22.
PMID: 3032784 DOI: 10.1007/BF00404424.
Cloning and analysis of HLA class I cDNA encoding a new HLA-C specificity Cx52.
Takata H, Inoko H, Ando A, Haranaka M, Watanabe B, Tsuji K Immunogenetics. 1988; 28(4):265-70.
PMID: 2843461 DOI: 10.1007/BF00345504.